プレシジョンメディシンの世界市場レポート 2025

プレシジョンメディシン市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）9.9％で1,293億7,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、がん有病率の増加、新興経済諸国の高い潜在力、新規病原性感染症の出現、研究開発費の増加、ヘルスケア支出の増加に起因すると考えられます。予測期間中の主な動向としては、競争力向上のための人工知能技術の採用、免疫介在性疾患の診断と個別化治療の提供、研究開発活動の拡大への投資、製品ポートフォリオを改善するためのテクノロジーおよびヘルスケア事業体との提携や協力関係の形成などが挙げられます。

がん罹患率の上昇がプレシジョンメディシン市場の成長を牽引すると予想されます。がんは依然として世界の死因の上位を占めており、5人に1人が生涯のどこかでがんに罹患する可能性があります。がんのプレシジョンメディシンでは、腫瘍DNAを解析し、疾患の原因となる変異や遺伝子異常を特定します。これにより、ヘルスケアプロバイダーは、患者の腫瘍の遺伝子変化をターゲットとして特別に調整された治療を選択することができます。例えば、2024年2月、スイスに本部を置き国際的な公衆衛生に重点を置く専門機関である世界保健機関（WHO）は、2050年までに新たに発生するがん患者は3500万人を超え、2022年の推定2000万人から77％増加すると予測しました。このように、がんの有病率の増加がプレシジョンメディシン市場の成長に拍車をかけています。

ヘルスケア支出の増加は、今後のプレシジョンメディシン市場の成長を促進すると予測されています。ヘルスケア支出には、医療機器、病院サービス、医師サービス、処方薬、公衆衛生イニシアチブなど、ヘルスケア商品やサービスに割り当てられる総資金が含まれます。このような支出は、プレシジョンメディシンの開発、採用、主流ヘルスケアへの統合を促進するために不可欠です。例えば、2023年5月、英国の政府部門である国家統計局の報告によると、英国のヘルスケア支出は2022年の0.9％増に対し、2022年から2023年にかけて5.6％増となった。2023年の英国のヘルスケア支出は約3,176億3,000万米ドル（2,920億英ポンド）。したがって、医療費の増加がプレシジョンメディシン市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界プレシジョンメディシンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のプレシジョンメディシン市場：成長率分析
• 世界のプレシジョンメディシン市場の実績：規模と成長, 2019-2024
• 世界のプレシジョンメディシン市場の予測：規模と成長, 2024-2029, 2034F
• 世界プレシジョンメディシン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のプレシジョンメディシン市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビッグデータ分析
• バイオインフォマティクス
• 遺伝子配列解析
• 創薬
• コンパニオン診断
• その他のテクノロジー
• 世界のプレシジョンメディシン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 呼吸器疾患
• 中枢神経系疾患
• 免疫学
• 遺伝性疾患
• その他の用途
• 世界のプレシジョンメディシン市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• 診断会社
• ヘルスケアおよびIT企業
• その他
• 世界のプレシジョンメディシン市場、ビッグデータ分析のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 予測分析
• 処方的分析
• データマイニング
• 世界のプレシジョンメディシン市場、バイオインフォマティクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ゲノムデータ分析
• プロテオミクスデータ解析
• メタボロミクスデータ分析
• 世界のプレシジョンメディシン市場、遺伝子配列のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 次世代シーケンシング（NGS）
• サンガーシーケンス
• 全ゲノム配列解析
• 世界のプレシジョンメディシン市場、創薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ターゲットの識別と検証
• リード化合物の発見
• 前臨床および臨床試験
• 世界のプレシジョンメディシン市場、コンパニオン診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオマーカー検査
• ゲノムプロファイリング
• コンパニオン診断テスト
• 世界のプレシジョンメディシン市場、その他のテクノロジーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パーソナライズされた治療計画
• 遠隔医療とデジタルヘルスソリューション
• ウェアラブルヘルステクノロジー

第7章 地域別・国別分析

• 世界のプレシジョンメディシン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のプレシジョンメディシン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プレシジョンメディシン市場：競合情勢
• プレシジョンメディシン市場：企業プロファイル
  • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Pfizer Inc.
• Qiagen
• AstraZeneca plc.
• Abbott Laboratories
• Nordic Bioscience A/S
• Takeda Pharmaceutical Company Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Daiichi Sankyo
• China National Pharmaceutical Group Co., Ltd.
• GE Healthcare
• Randox Laboratories
• Almac Group
• Sun Pharma
• Nichi-Iko Pharmaceutical Co., Ltd.
• Daewoong Pharmaceutical Co.,Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• プレシジョンメディシン市場2029：新たな機会を提供する国
• プレシジョンメディシン市場2029：新たな機会を提供するセグメント
• プレシジョンメディシン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Precision medicine refers to a form of medical treatment that involves the prevention, detection, or treatment of diseases based on an individual's genetic or protein-related information. In order to identify the most effective treatment for an individual, precision medicine takes into account factors such as their genetics, environment, and lifestyle.

The primary technologies associated with precision medicine include bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics technologies utilize computational tools to organize, analyze, understand, visualize, and store information related to biological macromolecules. Precision medicine is applied in various medical fields, including oncology, respiratory diseases, central nervous disorders, immunology, and genetic diseases. It is implemented across different sectors, including pharmaceuticals, diagnostic companies, healthcare, and IT firms.

The precision medicine market research report is one of a series of new reports from The Business Research Company that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision medicine market size has grown rapidly in recent years. It will grow from $80.15 billion in 2024 to $88.73 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increase in cancer prevalence, increasing prevalence of mental health disorders, increased prevalence of respiratory diseases, increasing funding, increased geriatric population, increase in pharmaceutical R&D expenditure and increased healthcare expenditure.

The precision medicine market size is expected to see strong growth in the next few years. It will grow to $129.37 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the increasing geriatric population, increasing prevalence of cancer, high potential of emerging economies, emergence of novel pathogenic infestations, increasing research and development spending and rise in healthcare expenditure. Major trends in the forecast period include adopting artificial intelligence technologies for improving competitiveness, offering diagnosis and personalized treatment for immune-mediated diseases, investing in increased research and development activities and forming collaborations and partnerships with technology and healthcare entities to improve their product portfolios.

The rising incidence of cancer is expected to drive the growth of the precision medicine market. Cancer remains a leading cause of death globally, with one in five individuals likely to develop the disease at some point in their lives. Precision medicine for cancer involves analyzing tumor DNA to identify mutations or genetic abnormalities that contribute to the disease. This allows healthcare providers to select treatments that are specifically tailored to target the genetic changes in a patient's tumor. For example, in February 2024, the World Health Organization, a Switzerland-based specialized agency focused on international public health, projected that by 2050, there will be over 35 million new cancer cases, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the increasing prevalence of cancer is fueling the growth of the precision medicine market.

Rising healthcare expenditure is anticipated to enhance the growth of the precision medicine market in the future. Healthcare expenditure encompasses the total funds allocated for healthcare goods and services, which include medical equipment, hospital services, physician services, prescription medications, and public health initiatives. Such expenditure is vital for promoting the development, adoption, and integration of precision medicine into mainstream healthcare. For instance, in May 2023, a report from the Office for National Statistics, a UK government department, indicated that healthcare spending in the UK grew by 5.6% from 2022 to 2023, compared to a 0.9% increase in 2022. In 2023, the UK's healthcare expenditure was approximately $317.63 billion (£292 billion). Therefore, the rising healthcare expenditure is driving the growth of the precision medicine market.

The increasing number of partnerships and acquisitions among precision medicine companies is facilitating their expansion into both oncology and non-oncology fields. Continuous research and development in precision medicine is enhanced through collaboration, allowing firms to strengthen their capabilities and approaches. For example, in September 2022, GSK plc, a UK-based pharmaceutical firm, broadened its collaboration with Tempus, a US-based precision medicine company. This three-year partnership aims to enhance clinical trial design, expedite patient enrollment, and identify drug targets by leveraging Tempus' AI-driven platform and extensive de-identified patient data. This collaboration builds on their previous efforts and is expected to strengthen GSK's R&D capabilities, especially in oncology.

Leading companies in the precision medicine market are focusing on innovations like data ingestion, which facilitates access to public datasets via Google Cloud's Analytics Hub. Data ingestion refers to the process of collecting and importing data from various sources into a storage system or data processing platform. For instance, in May 2023, Google Cloud, a US-based software development company, introduced two AI-powered solutions designed to enhance drug discovery and precision medicine. These new AI solutions are accelerating drug discovery and precision medicine in the biotech and pharmaceutical sectors. Researchers can now more efficiently identify protein structures and interpret genomic data, thus improving drug development processes. These tools reduce the time required to bring life-saving treatments to market and enhance collaboration among research teams. They also support multi-cloud environments for seamless integration.

In July 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Proteomics for an undisclosed amount. This acquisition aims to strengthen its capabilities in proteomics, a rapidly growing field focused on the large-scale study of proteins. Olink Proteomics is a Sweden-based biotechnology research company that contributes to precision medicine through its innovative technologies and services related to protein biomarker analysis.

Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, Uniao Quimica

North America was the largest region in the precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The precision medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology
• 2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.
• 3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others
• Subsegments:
• 1) By Big Data Analytics: Predictive Analytics; Prescriptive Analytics; Data Mining
• 2) By Bioinformatics: Genomic Data Analysis; Proteomics Data Analysis; Metabolomics Data Analysis
• 3) By Gene Sequencing: Next-Generation Sequencing (NGS); Sanger Sequencing; Whole Genome Sequencing
• 4) By Drug Discovery: Target Identification And Validation; Lead Compound Discovery; Preclinical And Clinical Trials
• 5) By Companion Diagnostics: Biomarker Testing; Genomic Profiling; Companion Diagnostic Tests
• 6) By Other Technology: Personalized Treatment Plans; Telemedicine And Digital Health Solutions; Wearable Health Technology
• Companies Mentioned: Quest Diagnostics; Thermo Fisher Scientific Inc.; Roche Holding AG; Medtronic plc; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Precision Medicine Market Characteristics

3. Precision Medicine Market Trends And Strategies

4. Precision Medicine Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Precision Medicine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Precision Medicine Market Growth Rate Analysis
• 5.4. Global Precision Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Precision Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Precision Medicine Total Addressable Market (TAM)

6. Precision Medicine Market Segmentation

• 6.1. Global Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Other Technology
• 6.2. Global Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Respiratory Diseases
• Central Nervous System Disorders
• Immunology
• Genetic Diseases
• Other Applications
• 6.3. Global Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Diagnostic Companies
• Healthcare And IT Firms
• Others
• 6.4. Global Precision Medicine Market, Sub-Segmentation Of Big Data Analytics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Analytics
• Prescriptive Analytics
• Data Mining
• 6.5. Global Precision Medicine Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomic Data Analysis
• Proteomics Data Analysis
• Metabolomics Data Analysis
• 6.6. Global Precision Medicine Market, Sub-Segmentation Of Gene Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS)
• Sanger Sequencing
• Whole Genome Sequencing
• 6.7. Global Precision Medicine Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Target Identification And Validation
• Lead Compound Discovery
• Preclinical And Clinical Trials
• 6.8. Global Precision Medicine Market, Sub-Segmentation Of Companion Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biomarker Testing
• Genomic Profiling
• Companion Diagnostic Tests
• 6.9. Global Precision Medicine Market, Sub-Segmentation Of Other Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Personalized Treatment Plans
• Telemedicine And Digital Health Solutions
• Wearable Health Technology

7. Precision Medicine Market Regional And Country Analysis

• 7.1. Global Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Precision Medicine Market

• 8.1. Asia-Pacific Precision Medicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Precision Medicine Market

• 9.1. China Precision Medicine Market Overview
• 9.2. China Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Precision Medicine Market

• 10.1. India Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Precision Medicine Market

• 11.1. Japan Precision Medicine Market Overview
• 11.2. Japan Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Precision Medicine Market

• 12.1. Australia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Precision Medicine Market

• 13.1. Indonesia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Precision Medicine Market

• 14.1. South Korea Precision Medicine Market Overview
• 14.2. South Korea Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Precision Medicine Market

• 15.1. Western Europe Precision Medicine Market Overview
• 15.2. Western Europe Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Precision Medicine Market

• 16.1. UK Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Precision Medicine Market

• 17.1. Germany Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Precision Medicine Market

• 18.1. France Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Precision Medicine Market

• 19.1. Italy Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Precision Medicine Market

• 20.1. Spain Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Precision Medicine Market

• 21.1. Eastern Europe Precision Medicine Market Overview
• 21.2. Eastern Europe Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Precision Medicine Market

• 22.1. Russia Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Precision Medicine Market

• 23.1. North America Precision Medicine Market Overview
• 23.2. North America Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Precision Medicine Market

• 24.1. USA Precision Medicine Market Overview
• 24.2. USA Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Precision Medicine Market

• 25.1. Canada Precision Medicine Market Overview
• 25.2. Canada Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Precision Medicine Market

• 26.1. South America Precision Medicine Market Overview
• 26.2. South America Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Precision Medicine Market

• 27.1. Brazil Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Precision Medicine Market

• 28.1. Middle East Precision Medicine Market Overview
• 28.2. Middle East Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Precision Medicine Market

• 29.1. Africa Precision Medicine Market Overview
• 29.2. Africa Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Precision Medicine Market Competitive Landscape And Company Profiles

• 30.1. Precision Medicine Market Competitive Landscape
• 30.2. Precision Medicine Market Company Profiles
  • 30.2.1. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Precision Medicine Market Other Major And Innovative Companies

• 31.1. Pfizer Inc.
• 31.2. Qiagen
• 31.3. AstraZeneca plc.
• 31.4. Abbott Laboratories
• 31.5. Nordic Bioscience A/S
• 31.6. Takeda Pharmaceutical Company Ltd.
• 31.7. Otsuka Pharmaceutical Co. Ltd.
• 31.8. Daiichi Sankyo
• 31.9. China National Pharmaceutical Group Co., Ltd.
• 31.10. GE Healthcare
• 31.11. Randox Laboratories
• 31.12. Almac Group
• 31.13. Sun Pharma
• 31.14. Nichi-Iko Pharmaceutical Co., Ltd.
• 31.15. Daewoong Pharmaceutical Co.,Ltd

32. Global Precision Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Precision Medicine Market

34. Recent Developments In The Precision Medicine Market

35. Precision Medicine Market High Potential Countries, Segments and Strategies

• 35.1 Precision Medicine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Precision Medicine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Precision Medicine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer